News
Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...
Verywell Health on MSN1d
Wegovy vs. Ozempic: Which Is the Better Weight Loss Drug?Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.
Opinion
Zacks Investment Research on MSN2dOpinion
Top Analyst Reports for Novo Nordisk, Honeywell & American TowerThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Honeywell ...
The Healthy @Reader's Digest on MSN1d
A Highly Popular Weight Loss Drug Has Been Recalled in 3 StatesJust today, this drug became more widely available. Some product is now facing a recall following an apparent storage error.
The “trendification” of Ozempic and semaglutide is putting immense ... Only three drugs – Novo Nordisk’s Wegovy and Saxenda, and Eli Lilly’s Zepbound – are actually approved for ...
Alternative compounded versions of Novo Nordisk’s blockbuster weight-loss and diabetes drugs have hurt its sales, ...
Nevertheless, Novo Nordisk’s diabetes drugs Ozempic and Rybelsus and obesity ... other indications like liver fibrosis and MASH for semaglutide. (You can read the full research report on Novo ...
The US Food and Drug Administration seized fake Ozempic injections. This happened on April 9, 2025. Novo Nordisk warned about these fake drugs. Elon Musk mentioned using a similar drug.
Unfortunately for Novo Nordisk investors, shares of the Danish pharmaceutical have dived by 36% across that stretch of time. We can't only blame Lilly for this. Given the massive demand for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback